ARK Genomic Revolution ETF Target of Unusually High Options Trading (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKGGet Free Report) was the recipient of unusually large options trading on Monday. Stock investors purchased 27,609 call options on the stock. This is an increase of approximately 155% compared to the typical volume of 10,820 call options.

ARK Genomic Revolution ETF Price Performance

Shares of ARK Genomic Revolution ETF stock traded up $0.87 during trading on Monday, hitting $42.30. 4,272,883 shares of the stock traded hands, compared to its average volume of 2,946,578. ARK Genomic Revolution ETF has a 52 week low of $22.73 and a 52 week high of $42.70. The firm’s fifty day moving average is $32.38 and its 200-day moving average is $30.33.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Ascentis Independent Advisors bought a new stake in shares of ARK Genomic Revolution ETF in the 1st quarter worth approximately $26,000. PNC Financial Services Group Inc. grew its holdings in shares of ARK Genomic Revolution ETF by 53.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock valued at $29,000 after purchasing an additional 378 shares during the last quarter. Sunbelt Securities Inc. raised its position in ARK Genomic Revolution ETF by 734.3% in the 3rd quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock worth $31,000 after purchasing an additional 984 shares during the period. Western Wealth Management LLC bought a new stake in ARK Genomic Revolution ETF in the first quarter worth $37,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in ARK Genomic Revolution ETF in the second quarter worth $38,000.

About ARK Genomic Revolution ETF

(Get Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

Recommended Stories

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.